Literature DB >> 7728353

Development of a meningococcal vaccine.

J T Poolman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7728353

Source DB:  PubMed          Journal:  Infect Agents Dis        ISSN： 1056-2044


× No keyword cloud information.
  16 in total

1.  Neisseria meningitidis lipopolysaccharide modulates the specific humoral immune response to neisserial porins but has no effect on porin-induced upregulation of costimulatory ligand B7-2.

Authors:  N Bhasin; Y Ho; L M Wetzler
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

2.  Structural Basis for the Immunogenic Properties of the Meningococcal Vaccine Candidate LP2086.

Authors:  Alessandro Mascioni; Breagh E Bentley; Rosaria Camarda; Deborah A Dilts; Pamela Fink; Viktoria Gusarova; Susan K Hoiseth; Jaison Jacob; Shuo L Lin; Karl Malakian; Lisa K McNeil; Terri Mininni; Franklin Moy; Ellen Murphy; Elena Novikova; Scott Sigethy; Yingxia Wen; Gary W Zlotnick; Désirée H H Tsao
Journal:  J Biol Chem       Date:  2008-12-22       Impact factor: 5.157

3.  Bactericidal and cross-protective activities of a monoclonal antibody directed against Neisseria meningitidis NspA outer membrane protein.

Authors:  N Cadieux; M Plante; C R Rioux; J Hamel; B R Brodeur; D Martin
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

4.  Specificity of bactericidal antibody response to serogroup B meningococcal strains in Brazilian children after immunization with an outer membrane vaccine.

Authors:  L G Milagres; M C Gorla; C T Sacchi; M M Rodrigues
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

Review 5.  Update on meningococcal disease with emphasis on pathogenesis and clinical management.

Authors:  M van Deuren; P Brandtzaeg; J W van der Meer
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

6.  Highly conserved Neisseria meningitidis surface protein confers protection against experimental infection.

Authors:  D Martin; N Cadieux; J Hamel; B R Brodeur
Journal:  J Exp Med       Date:  1997-04-07       Impact factor: 14.307

7.  Modification of lipid A biosynthesis in Neisseria meningitidis lpxL mutants: influence on lipopolysaccharide structure, toxicity, and adjuvant activity.

Authors:  P van der Ley; L Steeghs; H J Hamstra; J ten Hove; B Zomer; L van Alphen
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

8.  Use of the pre-pro part of Staphylococcus hyicus lipase as a carrier for secretion of Escherichia coli outer membrane protein A (OmpA) prevents proteolytic degradation of OmpA by cell-associated protease(s) in two different gram-positive bacteria.

Authors:  J Meens; M Herbort; M Klein; R Freudl
Journal:  Appl Environ Microbiol       Date:  1997-07       Impact factor: 4.792

9.  Neutralization of Neisseria meningitidis outer membrane vesicles.

Authors:  András Vida; Annet Troelstra; Péter Antal-Szalmás; Toon J P van Bommel; André F M Verheul; Jan Verhoef; Kok P M van Kessel; Jos A G van Strijp
Journal:  Inflamm Res       Date:  2011-05-24       Impact factor: 4.575

10.  Functional activities and immunoglobulin variable regions of human and murine monoclonal antibodies specific for the P1.7 PorA protein loop of Neisseria meningitidis.

Authors:  J Wang; G A Jarvis; M Achtman; E Rosenqvist; T E Michaelsen; A Aase; J M Griffiss
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.